Biocon has appointed Shreehas Tambe as the new CEO and MD of the company, with effect from April 1, 2026, and also appointed Kedar Upadhye as the chief financial officer of the firm.
Biocon has appointed Shreehas Tambe as the new CEO and MD of the company, with effect from April 1, 2026, and also appointed Kedar Upadhye as the chief financial officer of the firm.